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 BACKGROUND 
 Haemolysis after Rh isoimmunisation primarily causes 
anaemia in the intrauterine period but leads to jaundice 
and anaemia of variable intensity after birth. 1 This is the 
second article in the literature describing cases of Rh isoim-
munisation presenting in the early newborn period prima-
rily as anaemia without clinically signiﬁ cant jaundice. 2 
 Routine anti-D prophylaxis after delivery and at 28 
weeks of gestation has reduced the immunisation rate by 
90%, transforming the haemolytic disease of the newborn 
in a rare disease. 3  4 
 CASE PRESENTATION 
 We present the case of a term infant, born to a ‘B’ posi-
tive father and an ‘A’ negative second gravida mother. The 
mother received anti-D immune prophylaxis after the ﬁ rst 
delivery, but did not receive it during this second gestation. 
Her indirect antiglobulin tests in the second and third tri-
mester were negative. 
 The baby was born well, by normal vaginal delivery, 
without oedema, pallor, jaundice or hepatosplenomegaly. 
His birth weight was 4040 g. In the ﬁ rst day of life, he 
seemed to be a healthy baby, feeding well and without 
fatigue. On day 2 of life, he was found to be pale and the 
mother’s indirect antiglobulin test was positive. He had a 
severe macrocytic anaemia, with 6,8 g/dl of haemoglobin 
(Hb) and a mean globular volume of 123 fL. The peripheral 
blood smear showed anisopoikilocytosis and frequent eri-
troblasts. His reticulocyte count was 8,8% (normal value 
is 2–3%) and the lactic dehydrogenase level was elevated 
(5372 U/l; for a normal range of 500–920 U/l). However, 
total serum bilirubin (TSB) was 87 2 μmol/l and the uncon-
jugated fraction was 3 μmol/l. The direct antiglobulin test 
was positive. The baby’s blood group was ‘A’ positive. 
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 Summary 
 Rh isoimmunisation leads to haemolytic anaemia and hyperbilirubinaemia in the fi rst h of life. Isolated early onset neonatal anaemia has rarely 
been reported. The authors describe the case of a term infant, born to an ‘A’ negative, second gravida mother. On the second day of life, pallor 
was noticed. His haemoglobin (Hb) was 6.8 g/dl, he had reticulocytosis and a positive direct antiglobulin test. However, he did not have a high 
total serum bilirubin (TSB) (87.2 µmol/l). He was transfused with red blood cells and kept under phototherapy for 3 days. Three weeks later, 
he received another transfusion for severe anaemia (Hb 6 5 g/dl). During this period, he was never jaundiced and the maximum level of TSB 
was 122 µmol/l. On follow-up, his Hb stabilised and he had no further problems. This report highlights the possibility of early onset anaemia 
without jaundice as the sole manifestation of Rh isoimmunisation. 
 Figure 1  Progression of haemoglobin values after the fi rst red blood cell (RBC) transfusion, haemolysis persisted requiring a second RBC 
transfusion. 
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Phenotyping of Rh antigens revealed absence of antigens 
C, E and Kell (K), conﬁ rming an anti-D alloimmunisation. 
 TREATMENT 
 He was admitted in the Neonatal Intensive Care Unit for 
red blood cells (RBC) transfusion and he was started on 
prophylactic phototherapy for 3 days. On day 3, he had an 
unremarkable transfontanellar ultrasound and was started 
on oral folate three times a week. He was discharged home 
on day 9. During the hospital stay, he was never jaundiced 
and the maximum level of TSB was 122 μmol/l. 
 OUTCOME AND FOLLOW-UP 
 Two weeks later, in a follow-up evaluation, he presented 
with pallor, his Hb was 6 5 g/dl and there was no appre-
ciable increase in TSB. He received another RBC transfu-
sion and was discharged home. He was followed in the 
haematology clinic for 6 months and had no more signs 
of haemolysis. At this time folic acid supplements were 
stopped. 
 He is now 2 years old and has got a normal growth and 
mental development. 
 Figures 1 and  2 describe the progression of the values of 
Hb and bilirubin since birth and after discharge. 
 DISCUSSION 
 With this case we emphasise that Rh isoimmunisation in 
neonates can be presented as isolated anaemia without sig-
niﬁ cant hyperbilirubinaemia. 
 Rh isoimmunisation occurs when fetal RBCs from an Rh 
D positive fetus cross the placenta into the circulation of 
an Rh D negative mother. 2 Once sensitisation has taken 
place, considerably smaller doses of antigen can stimulate 
an increase in antibody titre. Initially, a rise in IgM anti-
body occurs, which is later replaced by IgG antibody; the 
latter readily crosses the placenta and causes haemolytic 
manifestations. 1 
 The severity of the disease may range from only labora-
tory evidence of mild haemolysis (15% of cases) to severe 
anaemia with compensatory hyperplasia of erythropoietic 
tissue leading to massive enlargement of the liver and the 
spleen. When the compensatory capacity is exceeded, pro-
found anaemia occurs and results in pallor, cardiac decom-
pensation, massive anasarca and circulatory collapse. 1 This 
clinical picture is termed hydrops fetalis and occurs in 20 to 
25% of Rh isoimmunisation cases. 2 
 Jaundice may be absent at birth because of placental 
clearance of unconjugated bilirubin. 1 However, it is gen-
erally evident on the ﬁ rst day of life because the infant’s 
bilirubin-conjugating and excretory systems are unable 
to cope with the load resulting from massive haemolysis. 
Therefore, unconjugated bilirubin accumulates postna-
tally and may rapidly reach high levels. 1 About 25 to 30% 
will require treatment with phototherapy or exchange 
transfusion. 2 
 Studies have shown that severe inutero haemolysis 
owing to Rh isoimmunisation and postnatal RBC transfu-
sions can lead to bone marrow suppression and may exag-
gerate anaemia. 5 The onset of this anaemia is late and is 
commonly seen after 2 weeks of age. Recent studies sug-
gest that the anaemia is most likely caused by the persist-
ence of anti-D antibodies and destruction of RBC. 6 
 As shown in reported cases, this infant required a 
repeated blood transfusion. This could be owing to the 
effect of circulating maternal anti-D antibodies, known to 
persist up to 6 to 8 weeks. 2 
 The clinical presentation of isolated anaemia in our 
report was early, severe and unassociated with jaun-
dice. In the literature, we found the description of three 
cases with similar caracteristics. 2 Louis D  et al explained 
that this could be possible after a low-to-moderate grade 
haemolysis with the bilirubin production balanced by an 
enhanced hepatic capacity to conjugate and excrete, leav-
ing behind anaemia as the predominant clinical manifes-
tation. 2 Red cell breakdown produces unconjugated (or 
 Figure 2  The blue line shows the bilirubin values, always under the recommended level to start phototherapy. 7 
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‘indirect’) bilirubin, which is mostly bound to albumin. 
Unconjugated bilirubin is metabolised in the liver, by 
glucoronil-transferase enzyme, to produce conjugated (or 
‘direct’) bilirubin, which then passes through the gut and 
is excreted in the stool. Bilirubin can be reabsorbed again 
from stools remaining in the gut. 7 We hypothesise that 
the absence of jaundice in this case may be related to an 
increased activation of the glucoronil-transferase enzyme 
allowing a fast conjugation of bilirubin. 
 Severe anaemia without hyperbilirubinaemia has been 
reported after anti-K isoimmunisation in which the anti-K 
antibodies cause bone marrow suppression. 8 In our report, 
the newborn was screened for C, E and K antibodies and 
was negative for all. 
 Intravenous immunoglobulin (IVIg) is a standard inter-
vention for preventing and reducing the severity of haemo-
lysis in isoimmunised infants. 5 However, in most studies, 
the neonates presented with signiﬁ cant jaundice in the 
early postnatal period. There have been no studies until 
this date, that have shown the beneﬁ cial role of IVIg in 
reducing haemolysis in infants presenting with severe 
anaemia without hyperbilirubinaemia. 2 In this case, IVIg 
was not administered and the outcome was favourable. 
 Learning points 
 ▶  Anaemia may be the only manifestation of Rh 
isoimmunisation. 
 The absence of jaundice or hyperbilirubinaemia does  ▶
not exclude haemolytic disease of the newborn. 
 Competing interests  None. 
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